Active Ingredient(s): Clobazam
FDA Approved: * November 1, 2018
Category: Anticonvulsant

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Sympazan Overview

Clobazam (marketed under the brand names Frisium, Urbanol, Onfi, and Tapclob ) is a benzodiazepine class medication that was patented in 1968[1] and has been marketed as an anxiolytic since 1975[2] and an anticonvulsant since 1984.[3] Contents 1 Medical uses 2 Contraindications 3 Side effects 3.1 Common 3.2 Post Marketing Experience 3.3 Warnings and Precautions 3.4 Drug interactions 3.5 Overdose 3.6 Abuse potential and addiction 3.7 Depende...

Read more Sympazan Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Sympazan Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Film: 10mg, 20mg, 5mg
  • Suspension: 2.5mg/ml
  • Tablet: 10mg, 20mg, 5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Sympazan: (3 results)

Sorted by National Drug Code
  • 10094-205 Sympazan 5 mg Oral Film by Aquestive Therapeutics
  • 10094-210 Sympazan 10 mg Oral Film by Aquestive Therapeutics
  • 10094-220 Sympazan 20 mg Oral Film by Aquestive Therapeutics

Other drugs which contain Clobazam or a similar ingredient: (3 results)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 25 January 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA